|
Post by gtay87 on Oct 31, 2016 11:48:41 GMT -5
I notice that some of Eric Fenar's early blogs highlighted his freedom to go to and enjoy a baseball game and other sporting events where he included photos of himself holding his Afrezza inhaler. I wouldn't be so quick to dismiss the impact of the program ad.
NOTE: If you want to view Eric's video in addition to this photo, here is the link: www.youtube.com/watch?v=_HGGgaKQDT0
---
I assumed from what Matt implied at he investors conference that MannKind got a terrific deal on the DTC ad.
It also may have been used to economically assess certain aspects of the new OUTsulin campaign before initiating more expensive advertising channels. But figure type 1s are about 0.4% of the population. So in a crowd of 50,000, you'd expect to reach about 200 type 1 customers. Wouldn't ads in magazines directed specifically towards diabetics be more cost efficient/effective?
|
|
|
Post by peppy on Oct 31, 2016 11:53:38 GMT -5
|
|
|
Post by mnholdem on Oct 31, 2016 12:02:31 GMT -5
I notice that some of Eric Fenar's early blogs highlighted his freedom to go to and enjoy a baseball game and other sporting events where he included photos of himself holding his Afrezza inhaler. I wouldn't be so quick to dismiss the impact of the program ad.
[photo]
NOTE: If you want to view Eric's video in addition to this photo, here is the link: www.youtube.com/watch?v=_HGGgaKQDT0
---
I assumed from what Matt implied at he investors conference that MannKind got a terrific deal on the DTC ad.
It also may have been used to economically assess certain aspects of the new OUTsulin campaign before initiating more expensive advertising channels. But figure type 1s are about 0.4% of the population. So in a crowd of 50,000, you'd expect to reach about 200 type 1 customers. Wouldn't ads in magazines directed specifically towards diabetics be more cost efficient/effective? True, which was why an Afrezza ad appeared in the fall edition of Diabetes Monitor magazine, featuring a cover story of diabetes advocate Laura Kronen. Incidentally, the ad was place within the pages of the feature story. As I indicated above, I think Mike got a deal with MLB and went with what he thinks was a good value for the $.
|
|
|
Post by derek2 on Oct 31, 2016 13:18:52 GMT -5
But figure type 1s are about 0.4% of the population. So in a crowd of 50,000, you'd expect to reach about 200 type 1 customers. Wouldn't ads in magazines directed specifically towards diabetics be more cost efficient/effective? True, which was why an Afrezza ad appeared in the fall edition of Diabetes Monitor magazine, featuring a cover story of diabetes advocate Laura Kronen. Incidentally, the ad was place within the pages of the feature story. As I indicated above, I think Mike got a deal with MLB and went with what he thinks was a good value for the $. T1s are still 40% of the insulin market, since 100% of T1s use insulin as opposed to 5% of T2s. Even fewer T2s use prandial insulin, since it's only added on after basal fails, but once again, all T1s use it (even pump users since it's fast acting insulin that's used in pumps). Which is to say, don't discount T1s.
|
|
|
Post by karma2 on Oct 31, 2016 13:32:59 GMT -5
Moderators should have locked this thread before the first "pro-tribe" post...sigh!
|
|
|
Post by mnholdem on Oct 31, 2016 13:38:15 GMT -5
|
|
|
Post by lakers on Nov 2, 2016 11:07:23 GMT -5
|
|
|
Post by madog365 on Nov 2, 2016 11:12:43 GMT -5
can anyone confirm whether afrezza ads have been present in the game guides during world series?
|
|
|
Post by slugworth008 on Nov 2, 2016 13:27:35 GMT -5
CUBS fans wouldn't be the same miserable suffering lot if they win the series. Go Tribe!
|
|